Details
Early recognition of AL amyloidosis is critical to improving patient outcomes. This new guideline aims to raise awareness of the signs and symptoms of AL amyloidosis across haematology, cardiology, neurology, renal and general clinics, supporting earlier diagnosis and treatment before significant organ damage occurs.